Table 1.
Variant | Em (mV vs SHE) | Proposed Redox Reactions and Ligand Exchange Processes |
---|---|---|
T78C/K79G solution | 22 ± 7 (82 ± 3)c |
CysFe(III)→MetFe(III)↔MetFe(II) (MetFe(II)↔MetFe(III)→CysFe(III))c |
T78C/K79G/M80Ld | −340 | CysFe(III)↔CysFe(II) |
K73A/K79G/M80K | −94 ± 2 | LysFe(III)↔LysFe(II) |
K79G | 266 ± 2 | MetFe(III)↔MetFe(II) |
WT* | 247 ± 4 | MetFe(III)↔MetFe(II) |
M80A | −80 ± 5 | (OH−)Fe(III)↔Fe(II) |
T78C/K79G-maleimide | 63 ± 4 (51 ± 5)c |
LysFe(III)→MetFe(III)↔MetFe(II) (MetFe(II)↔MetFe(III)→LysFe(III))c |
T78C/K79G crystal drope | 83; −160 | CysFe(III)→MetFe(III)↔Met(FeII); (OH−)Fe(III)↔Fe(II) and/or LysFe(III)↔LysFe(II) |
All variants contained two background mutations K72A and C102S, to prevent Lys72 coordination to the heme iron and formation of Cys102-linked dimers, respectively.
The observed potentials are strongly affected when there is coupling to a ligand exchange process.
Reductive (oxidative) direction.
From ref. 32.
A mixture of heme-ligated species, from direct electrochemistry measurements (Figure S11).